Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma

Translated title of the contribution: Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma

H.M. Lokhorst, P. Sonneveld, J.J. Cornelissen, P. Joosten, M. van Marwijk Kooy, J. Meinema, H.K. Nieuwenhuis, M.H.J. van Oers, D.J. Richel, C.N. Segeren, G. Veth, L.F. Verdonck, P.W. Wijermans

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionInduction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma
Original languageUndefined/Unknown
Pages (from-to)317-322
Number of pages6
JournalBone Marrow Transplantation
Volume23
Publication statusPublished - 1999

Cite this